SCP-400
Unknown
~
medium confidence
SCP-400
Expected annual
$7.5M
One-time setup
$2.1M
Annual recurring
$7.4M
Personnel
16
Initial capital and lab buildout (~$2.1M) driven by high-containment retrofits and core scientific equipment; recurring costs dominated by specialized personnel, MTF readiness, amnestic stockpiles and contingency reserves (~$7.39M/yr).
One-Time Capital Costs
Total: $2.1M
Annual Recurring Costs
Total: $7.4M/yr
Cost Scenarios
📊
Baseline
(baseline)
$7.4M/yr
Normal operational year with no major outbreaks or containment breaches; routine research, maintenance, personnel and readiness expenses only.
steady_containment
no_field_outbreaks
🚨
Moderate Outbreak
$8.0M/yr
Localized field infestation requiring quarantine, regional amnestic administration, short MTF deployment(s) and increased PR/legal activity.
localized_infestation
field_quarantine
amnestic_administration
🚨
Major Breach
$12.4M/yr
Large-scale outbreak affecting a population center (>500), requiring mass amnestic deployment, major MTF surge, and full contingency fund drawdown.
population_center_outbreak
mass_amnestics
MTF_surge
🚨
Research Breakthrough Requiring Scale Up
$10.4M/yr
Major R&D result (e.g., pheromone neutralization path) triggers accelerated scale-up: new facilities, expanded capital purchases and expanded staffing.
successful_countermeasure_R&D
facility_expansion
capital_procurement
Personnel
16 total
| Role | Count | Notes |
|---|---|---|
| Containment Handlers (BSL-4 technicians) | 4 | [#7] Notes specify 2–4 dedicated handlers; budgeted 4 handlers for 24/7 coverage. |
| Research Scientist | 4 | [#13] Geneticists/behavioral scientists/entomologists; budgeted 4 FTE (3–6 range) to match recurring research personnel cost. |
| Security Officer / MTF Agent | 6 | [#9] Additional guard postings for 24/7 site security; notes specify ~6 guards. |
| Medical Officer / Nursing Staff | 2 | [#8] 1–2 dedicated medical staff for quarantine and emergency care; budgeted 2 FTE. |
Confidence Notes
Many line items are explicitly specified with ranges in analyst notes (personnel, MTF readiness, amnestic costs), enabling mid-range estimates, but substantial uncertainty remains for per-event outbreak frequency, contingency sizing, and potential requirement for new BSL-4 facilities; therefore confidence is medium.